Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck

Showing 15 posts of 360 posts found.

Merck image

Late-stage failure for Merck and Threshold cancer drug

December 7, 2015
Research and Development, Sales and Marketing Merck, Pancreatic cancer, Threshold Pharmaceuticals, evofosfamide, late-stage failure, phase III, sarcoma

Merck and its development partner Threshold Pharmaceuticals say they will not pursue regulatory approval for evofosfamide in advanced soft tissue …

News
keytruda

Lilly and Merck extend immuno-oncology collaboration

November 20, 2015
Medical Communications, Research and Development Eli Lilly, Merck

Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …

News
Merck

Merck KGaA completes $17bn Sigma-Aldrich acquisition

November 18, 2015
Manufacturing and Production, Sales and Marketing M&A Sigma Aldridge, Merck, acquisitions, mergers

Merck KGaA has announced the completion of its $17 billion acquisition of Sigma-Aldrich, having cleared the final regulatory hurdle and …

News
new Merck sign

Merck achieves 7% sales growth in Q3 2015

November 12, 2015
Sales and Marketing Merck, Rebif, financial results

German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …

News
nsclc_merck_pfizer

Merck and Pfizer begin new Phase III avelumab trial in lung cancer

November 5, 2015
Medical Communications, Research and Development Merck, Pfizer, avelumab, lung cancer, non-small cell lung cancer

Merck and Pfizer have commenced an international Phase III study of the investigational cancer immunotherapy avelumab in patients with non-small …

News
lradvanyi_2

Merck appoints Laszlo Radvanyi as head of global immuno-oncology research

November 4, 2015
Research and Development Laszlo Radvanyi, Merck

Dr Laszlo Radvanyi has joined Merck as senior vice president and head of research in immuno-oncology.  The Merck Group says …

Appointment
GSK building

GSK and Merck to study immunotherapy combo in solid tumours

November 3, 2015
Research and Development GSK, Merck, immunooncology, immunotherapy, keytruda, phase I

GSK and Merck will start a Phase I clinical trial in humans to evaluate GSK’s investigational cancer drugs with the …

News
Merck R&D

Merck and Selvita form oncology partnership

November 2, 2015
Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology

Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …

News
Merck image

Sales up at MSD while Keytruda hits survival target in late-stage trial

October 28, 2015
Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab

Worldwide sales at MSD were $10.1 billion in the third quarter of 2015, a 4% increase after accounting for the …

News
New Merck logo

COMPANY PROFILE: The secrets of that Merck rebrand

October 23, 2015
Medical Communications, Sales and Marketing Merck, branding, communications, corporate logo, reputation

Merck’s recent rebrand may have left many scratching their heads, as the company moved away from the clinical professionalism of …

Feature
pi

Physicians Interactive acquires Univadis portal

October 22, 2015
Medical Communications, Sales and Marketing Merck, Physicians Interactive, Univadis

Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …

News
Ablynx flags

Ablynx and Merck begin immuno-oncology collaboration

October 15, 2015
Research and Development Ablynx, Merck, immuno-oncology, nanobody, proof of concept

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …

News
MSD logo

Merck and Incyte to initiate Keytruda, epacadostat combo trial

October 15, 2015
Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …

News

Merck rebrands as ‘science and technology’ company

October 14, 2015
Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …

News
998056_515738608494989_261353558_n

Merck improves manufacturing program

October 13, 2015
Manufacturing and Production Merck, Merck Millipore, manufacturing, production

Merck Millipore, the life science business arm of Merck KGaA, has introduced enhancements to its Emprove portfolio of raw pharmaceutical …

News

Latest content

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024

EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention

July 1, 2024

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024